Call for Abstract
8th Asia Pacific STD and Infectious Diseases Congress, will be organized around the theme “"Fight the Fight, Find the Cure"”
STD Asia Pacific 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in STD Asia Pacific 2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
The term ‘Sexually Transmitted Diseases’ (abbreviated STDs) alludes to a cluster of sicknesses that can be transmitted starting with one individual then onto the next through the sharing of body liquids, including discharge, vaginal liquids, blood, and different liquids. They have a wide range of causes (counting microscopic organisms and infections), they deliver an assortment of manifestations (or nonattendance of side effects), and they have altogether different impacts on the body when left untreated.
Sexually transmitted diseases are transmitted when body liquids from a contaminated individual come into hint contact with someone else. As their name infers, the most well-known course through which this body liquid sharing happens is sexual action.
- Track 1-1Chlamydia
- Track 1-2Gonorrhea
- Track 1-3Genital Herpes
- Track 1-4Syphilis
- Track 1-5Human Papillomavirus
- Track 1-6Viral Hepatitis
Virus a small infectious organism smaller that than a fungus and bacterium which invades a host cell to replicate. Viral infection incorporates a series of steps with attachment to the host cell to the be first following with transfer of RNA or DNA for the replication process of the virus.
- Track 2-1Cytomegalovirus
- Track 2-2Genital Warts
- Track 2-3Hepatitis
- Track 2-4Herpes
- Track 2-5Respiratory infections
- Track 2-6Gastrointestinal tract Infections
- Track 2-7Neural Infection
- Track 2-8Viral Tumorigenesis
- Track 2-9Molecular mechanisms of Viral Infection
Venereal diseases also termed as bacterial infection commonly spread by sex. These STIs when acquired before or during birth results in birth defects and might also cause the inability to be pregnant.
- Track 3-1Chancroid
- Track 3-2Chlamydia
- Track 3-3Gonorrhea
- Track 3-4Lymphogranuloma Venereum
- Track 3-5Mycoplasma Genitalium
- Track 3-6Syphilis
- Track 3-7Molecular Mechanism of Bacterial STI
- Track 3-8Zinc Deficiencies and Bacterial Infection
Pathogenic organisms are the agents of infectious diseases. Directly or indirectly from one person to another these infectious diseases can give rise to various devastating health issues.
There are a few ways that a parasite can contaminate a host. Numerous parasites go through messy water. Water borne pathogens are normal in places where the water is untreated and polluted by sewage. It is appalling however the most ideal route for such a parasite to taint another host is to go out of the old host in dung and afterward get again into another host when water sullied by sewage is devoured.
- Track 4-1Trichomoniasis
- Track 4-2Toxoplasmosis
- Track 4-3Babesiosis
- Track 4-4Giardiasis
- Track 4-5Drug Targets and Mechanisms of resistance
The relationship between infertility, birth defects with infection is long known. Asymptomatic infections caused by certain infections are more devastating as the absence or lack of symptoms prevents the patients from seeking timely medical intervention which consequently leads to chronic damage of the pelvic organs.
Chlamydia, among the most common sexually transmitted diseases, affects an estimated 100,000 pregnant women each year, according to the Centers for Disease Control and Prevention.
Premature birth of the baby which happens before 37 weeks of the pregnancy. Birth defects which is the abnormal shapes and function of the baby.
- Track 5-1Genetic disorder
- Track 5-2Poor growth
- Track 5-3Premature birth
- Track 5-4Pelvic Inflammatory Disease
- Track 5-5Mental retardation
- Track 5-6Low birth weighs
Emerging Infectious Diseases are those whose incidence or geographic range is rapidly increasing or threatens to increase in the near future. The rise of new infectious diseases or the re-emergence of the old infectious diseases is favored by many factors like evolution of the pathogens, human behavior and practice.
The emerging diseases can be established by its introduction into a population and its ability to spread from one person to another. Many emerging and re-emerging infectious diseases have been discovered like Hemorrhagic fever, Encephalitis, Zika virus & West nile virus etc.
- Track 6-1Hemorrhagic fever
- Track 6-2Encephalitis
- Track 6-3Yellow fever
- Track 6-4Anthrax
- Track 6-5Rabies
- Track 6-6Malaria and Chickungunya
- Track 6-7Cardiovascular Diseases
- Track 6-8Renal and Urologic Abnormalities
- Track 6-9Measles
- Track 6-10HIV & Polio virus
- Track 6-11Zika virus & West nile virus
Regardless of whether an irresistible illness operator is an "old associate" or another, developing risk, the safe framework's fight against it is typically the first line of defense. The immune response is the only way to eradicate the infectious disease when the medication is unavailable.
- Track 7-1Roles of Core Groups
- Track 7-2Sexually transmitted infection (STI)-related enteric infections
- Track 7-3Infection strategies through pathogen Human Protein- Protein Interactions
- Track 7-4Antigenic variations a way of escape for pathogens
The immune response to an infection depends if the infection is for the first time or the infection has occurred before. When the pathogen has already attacked once and has generated the memory cells in the host the response to the infection will be intense on the next exposure. The immune response to the foreign body in the host is due to series of other response from the immune cells.
- Track 8-1T helper cells response
- Track 8-2Regulatory T cells response
- Track 8-3Memory T cells response
- Track 8-4B cells and Antibody Factory response
- Track 8-5Mechanism of action of Antibody response
Effective new quality altering procedures guarantee noteworthy open doors for novel remedial alternatives to important illnesses, including cancer, genetic disorders and viral infections. Techniques like zinc finger nuclease, transcription activator-like effector nucleases and clustered regulatory interspaced short palindromic repeat.
- Track 9-1Designer Nucleases approach
- Track 9-2Gene manipulations approach
- Track 9-3Anti HIV gene approach
From recent years, the advancement and use of sub-atomic analytic systems had made a transformation in the finding and checking of infectious diseases. Molecular diagnostics are utilized to distinguish irresistible infections like chlamydia, flu infection and tuberculosis. Hereditary distinguishing proof can be made for instance loop-mediated isothermal enhancement test analyze the intestinal sickness parasite in the developing countries. In spite of these advances in genome examination, in 2013 diseases are still more regularly distinguished by different means like proteome, bacteriophage, or chromatographic profile. Sub-atomic diagnostics are utilized to comprehend the particular strain of the pathogen—for instance by recognizing which sedate resistance qualities it has—and consequently which treatments to maintain a strategic distance from.
- Track 10-1Hybridization techniques
- Track 10-2Amplification techniques
- Track 10-3Assays used in Epidemiological investigations
The Centers for Disease Control and Prevention (CDC) propose HIV testing as a normal piece of medicinal watch over pre-adult or grown-up between the ages of 15 and 65 at any least once. Sexually transmitted diseases might be identified amid a physical exam; through Pap smears; and in trial of pee, blood, and genital and butt-centric emissions. For STDs– like herpes, hepatitis, HIV and syphilis, a little blood test is utilized for the STD testing while chlamydia and gonorrhea test is finished with a pee test.
- Track 11-1Antibody Tests
- Track 11-2HIV RNA
- Track 11-3Whiff Test
- Track 11-4Immune chromatographic Assays
- Track 11-5Nucleic Acid Amplification Tests
- Track 11-6CSF examination
Medication revelation and development is an expensive procedure due to the high expenditure in the R&D and human clinical trials testing. The normal aggregate cost per medicate improvement differs from US$ 897 million to US$ 1.9 billion. The run of the mill improvement time is 10-15 years. For the research of the new drug it involves the identification of the target site for the drug interaction for the blocking process.
- Track 12-1Anti-HIV Drug Discovery
- Track 12-2LASER ART (long acting slow effective release antiretroviral therapy)
- Track 12-3Expedited Partner Therapies
- Track 12-4Jarisch-Herxheimer reactions
- Track 12-5Bacterial Azurin a novel anticancer agent
Infectious diseases counteractive action and control is useful to keep the transmission of irresistible infections. STI control endeavors have progressively been characterized in connection to HIV program needs hat are funded, implemented and evaluated independently of other STI control efforts. STI control is a public health outcome, measured as reduced incidence and prevalence, achieved by implementing strategies composed of multiple synergistic interventions.
- Track 13-1Good hygienic practices
- Track 13-2Diagnosis of infectious diseases
- Track 13-3HPV Vaccines
- Track 13-4Genital Herpes vaccines
- Track 13-5Antiviral therapy
- Track 13-6Tetracycline tablets
- Track 13-7Ciprofloxacin
2.3 million HIV infections were discovered globally. Large part of the population discovered with HIV infection discovered was in their reproductive stage and the men and women diagnosed with HIV were likely to want children. Perinatal transmission of HIV, also called as Vertical Transmission, occurs when HIV is infected from HIV-positive women to her baby during pregnancy, labor and delivery or breastfeeding. The percentage of transmission ranges from 15 to 45% during pregnancy, labor and delivery. The rate of transmission increases to additional 35 to 45% when there is breast feeding by the mother to child. The transmission rate depends on the type of STD and the mode of transfer.
- Track 14-1Types of STD during pregnancy
- Track 14-2Drugs for prevention of MTCT
- Track 14-3STD affects during pregnancy
In today’s world the sexually transmitted diseases are one of the most critical health challenges. Nearly 500 new million new cases of STD are registered per year and the individuals infected are in the age limit of 15 to 44 years. The STDs global testing market was valued at $107,024 million in 2015, and estimated to reach $190,010 million by 2022, registering a CAGR of 8.5% over the forecast period. Microfluidics is probable grow fastest, growing at a CAGR of 34.2% owing to the ease of use, technological advancements, and quick results in diagnostics.
- Track 15-1STD-AIDS Testing Market by testing devices
- Track 15-2STD-AIDS Testing Market by location
- Track 15-3STD-AIDS Testing Market by geography
- Track 15-4Private & public laboratory testing
- Track 15-5Technological Advancements for STDs diagnostic market
- Track 15-6Market Dynamics
Ebola hemorrhagic caused by virus belonging to the family Filoviridae which is also called as Filovirus. This virus is also known as Zoonotic Virus as it is transmitted from animals to humans. This disease was first appeared in 1976 in 2 simultaneous outbreaks but the largest outbreak was discovered in West Africa which was also the most complex outbreak from the time it was discovered. Fruit bats of the Pteropodidae family are natural Ebola virus hosts the transmission is done from the by the close contact with the blood.
- Track 16-1Ebola Outbreak
- Track 16-2Ebola Epidemiology and advances
- Track 16-3Molecular genetics of Ebola Virus
- Track 16-4Experimental Treatments for Ebola Viral Disease
- Track 16-5Molecular mechanisms of Ebola Virus Pathogenesis
The transfer of the pathogens causing the diseases can be form one person to another. But when the disease is transferred from animals to humans the disease is been termed as zoonotic diseases. The mode of transfer of the infectious agents can be in many ways like direct contact, indirect contact, vector-borne, food borne.
- Track 17-1Routes of Transmission and Mechanism
- Track 17-2Molecular genetic of Zoonotic Diseases
- Track 17-3Symptoms and Drug treatment
That bioinformatics pathogen profiling can help to predict the patient outcome and also find the markers for the early diagnosis and prevent the devastating outcomes. Using bioinformatics as the tool a pathogen profile can be considered as a single multivariate observation or a set of observations, comprised of classes of specific attributes, which are designed for a comparison with a knowledgebase. The presence of several repetitive sequences in the genome of the pathogen can be used for the comparison.
- Track 18-1Genotyping assisted infectious disease control
- Track 18-2Genome profiling of the pathogens
- Track 18-3Phylogenetic tree analyses
- Track 18-4Detection of the pathogen
- Track 18-5Infectious Diseases modeling
- Track 18-6Advancements in bioinformatics for Diagnosis
Enzymatic destruction, enzymatic modification, altered target and decreased uptake are the various ways by which the pathogenic organism shows resistance to the antimicrobial substance. The resistance is brought about by the alteration in the target site or the modification or the inactivation of the antibiotic, modification of metabolic pathway to reduce the antibiotic effect to the organism, decreasing the influx by decreasing the permeability.
- Track 19-1Genetic Jugglery for resistance
- Track 19-2Intrinsic Resistance for survival
- Track 19-3Resistome for the resistance
- Track 19-4Modes and mechanisms of transmission
Medical knowledge mapped into relational database forms the backbone to index diseases information. Infectious diseases relational database forms the decision-support tool for health professionals. To identify or diagnoses infectious diseases, information mapped into relational database offers the link with the data of the known relational. 275 infectious diseases are classified by category, disease type, and acuity. Categories include Arthropod-Borne, Biological Weapons, Childhood Infections, Community-Acquired, Foodborne, Gastroenteritis, Localized Infections, Sapronoses, Sexually-Transmitted, and Zoonoses. Disease types are Bacteria, Fungus, Helminth, Mixed, Other, Protozoa, Rickettsia, Spirochete, Toxin, and Virus.
- Track 20-1Advancements in Construction method of Databases
- Track 20-2Levels of Databases
- Track 20-3Database for Annotation, Visualization, and Integrated Discovery
Tumor and irresistible maladies are absolutely unmistakable classes of sicknesses. In any case, now and again they may give comparative indications and signs. They are however treated with various modalities of treatment. Typically, irresistible maladies don't convey the desolate viewpoint of harmful tumors, although an infection may be fatal or develop at the end of treatment of a cancer.
- Track 21-1HVP mode of cancer development
- Track 21-2Bacterially driven carcinogenesis
- Track 21-3Invasive fungal infection and cancer